UP inhibits LTD in the hippocampus via regulation of GSK3β

被引:580
|
作者
Peineau, Stephane
Taghibiglou, Changiz
Bradley, Clarrisa
Wong, Tak Pan
Liu, Lidong
Lu, Jie
Lo, Edmond
Wu, Dongchuan
Saule, Emilia
Bouschet, Tristan
Matthews, Paul
Isaac, John T. R.
Bortolotto, Zuner A.
Wang, Yu Tian
Collingridge, Graham L.
机构
[1] MRC, Ctr Synapt Plast, Dept Anat, Sch Med Sci, Bristol BS8 1TD, Avon, England
[2] Univ British Columbia, Brain Res Ctr, UBC Hosp, Vancouver, BC V6T 1Z3, Canada
[3] Univ British Columbia, Dept Med, UBC Hosp, Vancouver, BC V6T 1Z3, Canada
[4] NINDS, NIH, Bethesda, MD 20892 USA
基金
英国医学研究理事会;
关键词
D O I
10.1016/j.neuron.2007.01.029
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Glycogen synthase kinase-3 (GSK3) has been implicated in major neurological disorders, but its role in normal neuronal function is largely unknown. Here we show that GSK3 beta mediates an interaction between two major forms of synaptic plasticity in the brain, N-methyl-D-aspartate (NMDA) receptor-dependent long-term potentiation (LTP) and NMDA receptor-dependent long-term depression (LTD). In rat hippocampal slices, GSK3 beta inhibitors block the induction of LTD. Furthermore, the activity of GSK3 beta is enhanced during LTD via activation of PP1. Conversely, following the induction of LTP, there is inhibition of GSK3 beta activity. This regulation of GSK3 beta during LTP involves activation of NMDA receptors and the PI3K-Akt pathway and disrupts the ability of synapses to undergo LTD for up to 1 hr. We conclude that the regulation of GSK3 beta activity provides a powerful mechanism to preserve information encoded during LTP from erasure by subsequent LTD, perhaps thereby permitting the initial consolidation of learnt information.
引用
收藏
页码:703 / 717
页数:15
相关论文
共 50 条
  • [41] Discrete functions of GSK3α and GSK3β isoforms in prostate tumor growth and micrometastasis
    Gao, Fei
    Al-Azayzih, Ahmad
    Somanath, Payaningal R.
    ONCOTARGET, 2015, 6 (08) : 5947 - 5962
  • [42] Selective Toxicity by HDAC3 in Neurons: Regulation by Akt and GSK3β
    Bardai, Farah H.
    D'Mello, Santosh R.
    JOURNAL OF NEUROSCIENCE, 2011, 31 (05): : 1746 - 1751
  • [43] GSK3 as a pathogenic kinase in tauopathy and the use of GSK3 inhibitors such as Lithium as a therapeutic
    Duff, Karen
    Planel, Emmanuel
    Noble, Wendy
    MOVEMENT DISORDERS, 2008, 23 (08) : 1197 - 1197
  • [44] Discrete Functions Of GSK3α And GSK3β Isoforms In Prostate Tumor Growth And Micrometastasis
    Gao, Fei
    Al-Azayzih, Ahmad
    Shenoy, Somanath P. R.
    FASEB JOURNAL, 2015, 29
  • [45] Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
    Beurel, Eleonore
    Grieco, Steven F.
    Jope, Richard S.
    PHARMACOLOGY & THERAPEUTICS, 2015, 148 : 114 - 131
  • [46] GSK3β inhibits epithelial-mesenchymal transition via the Wnt/β-catenin and PI3K/Akt pathways
    Zhang, Cheng
    Su, Li
    Huang, Li
    Song, Zheng-Yu
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2018, 11 (07) : 1120 - 1128
  • [47] Primary Blast-Induced Changes in Akt and GsK3β Phosphorylation in Rat Hippocampus
    Wang, Yushan
    Sawyer, Thomas W.
    Tse, Yiu Chung
    Fan, Changyang
    Hennes, Grant
    Barnes, Julia
    Josey, Tyson
    Weiss, Tracy
    Nelson, Peggy
    Wong, Tak Pan
    FRONTIERS IN NEUROLOGY, 2017, 8
  • [48] GSK3β inhibits epithelial-mesenchymal transition via the Wnt/β-catenin and PI3K/Akt pathways
    Cheng Zhang
    Li Su
    Li Huang
    Zheng-Yu Song
    International Journal of Ophthalmology, 2018, 11 (07) : 1120 - 1128
  • [49] Regulation of brassinosteroid signaling by a GSK3/SHAGGY-like kinase
    Li, JM
    Nam, KH
    SCIENCE, 2002, 295 (5558) : 1299 - 1301
  • [50] Numb is induced by GSK3 inhibition and inhibits melanoma migration, invasion and metastasis
    Hristova, D.
    Hua, X.
    Wang, J.
    Li, L.
    Beqiri, M.
    Watters, A.
    Vultur, A.
    Wei, Z.
    Herlyn, M.
    Fukunaga-Kalabis, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (05) : S117 - S117